Home › Sjogren's Syndrome › Texas › Arlington
Sjogren's Syndrome clinical trials in Arlington, TX
4 studies for Sjogren's Syndrome are looking for participants at sites in and around Arlington (within about 30 miles). Open a study to see who can join and how to contact the study team.
Two Arm, Double-blind, Phase III Study Assessing Efficacy and Safety of Ianalumab Versus Placebo, in Participants With Sjögren's Disease With High Symptom Burden
RecruitingPhase 3
- Precision Comprehensive Clinical Research Solutions, Euless · 7 mi away
Phase 3 Study of Telitacicept in Active Primary Sjögren's Disease
RecruitingPhase 3
- Precision Comprehensive Clinical Research Solutions, Euless · 7 mi away
AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.
RecruitingPhase 2
- Artiva Investigational Site Arlington, Arlington
A Long-term Extension Study of Dazodalibep in Participants With Sjögren's Syndrome (SS)
RecruitingPhase 3
- Precision Comprehensive Clinical Research Solutions, Colleyville · 10 mi away
About Sjogren's Syndrome
Sjogren's Syndrome is an autoimmune disease that causes dryness of the mouth, eyes and other parts of the body. Learn how to relieve the symptoms.
More about Sjogren's Syndrome on MedlinePlus
Sjogren's Syndrome trials in other cities
- Houston, TX6 studies
- Washington, DC5 studies
- Boston, MA5 studies
- Tampa, FL4 studies
- Cicero, IL4 studies
- Charlotte, NC4 studies
- Orlando, FL3 studies
- Chicago, IL3 studies
- Warren, MI3 studies
- Dallas, TX3 studies
- Kansas City, MO3 studies
- Clearwater, FL3 studies
Other studies in Arlington
- Steatotic Liver Disease6 studies
- Crohn's Disease5 studies
- Non-Small Cell Lung Cancer4 studies
- Chronic Kidney Disease4 studies
- Atopic Dermatitis (Eczema)4 studies
- Lupus4 studies
- Psoriatic Arthritis4 studies
- Ulcerative Colitis4 studies
- Rheumatoid Arthritis4 studies
- Colorectal Cancer3 studies
- Cardiovascular Disease3 studies
- Prostate Cancer3 studies
From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.